Generic Oncology Drugs Market Report

Global and Region Generic Oncology Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：214
  • REPORT CODE：GMM1012374
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Generic Oncology Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Generic Oncology Drugsmarket, defines the market attractiveness level of Generic Oncology Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Generic Oncology Drugs industry, describes the types of Generic Oncology Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Generic Oncology Drugs market and the development prospects and opportunities of Generic Oncology Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Generic Oncology Drugs market in Chapter 13.

    By Player:

    • GlaxoSmithKline

    • Hikma Pharmaceuticals

    • Novartis

    • Merck

    • Celgene

    • Teva Pharmaceutical

    • Mylan

    • Pfizer

    • Aurobindo Pharma

    • Natco Pharma

    By Type:

    • Large Molecule Drugs

    • Small Molecule Drugs

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Generic Oncology Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Generic Oncology Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Generic Oncology Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Generic Oncology Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Generic Oncology Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Generic Oncology Drugs Consumption (2017-2022)

    • 7.2 United States Generic Oncology Drugs Consumption (2017-2022)

    • 7.3 Europe Generic Oncology Drugs Consumption (2017-2022)

    • 7.4 China Generic Oncology Drugs Consumption (2017-2022)

    • 7.5 Japan Generic Oncology Drugs Consumption (2017-2022)

    • 7.6 India Generic Oncology Drugs Consumption (2017-2022)

    • 7.7 South Korea Generic Oncology Drugs Consumption (2017-2022)

    8 Region and Country-wise Generic Oncology Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Generic Oncology Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Generic Oncology Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Generic Oncology Drugs Consumption Forecast (2022-2028)

    • 8.4 China Generic Oncology Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Generic Oncology Drugs Consumption Forecast (2022-2028)

    • 8.6 India Generic Oncology Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Generic Oncology Drugs Consumption Forecast (2022-2028)

    9 Global Generic Oncology Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Generic Oncology Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Large Molecule Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Generic Oncology Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Generic Oncology Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Generic Oncology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Large Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Generic Oncology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Generic Oncology Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Generic Oncology Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Generic Oncology Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Generic Oncology Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Generic Oncology Drugs Market Competitive Analysis

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Details

      • 14.1.2 GlaxoSmithKline Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline Generic Oncology Drugs Product and Service

    • 14.2 Hikma Pharmaceuticals

      • 14.2.1 Hikma Pharmaceuticals Company Details

      • 14.2.2 Hikma Pharmaceuticals Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Hikma Pharmaceuticals Generic Oncology Drugs Product and Service

    • 14.3 Novartis

      • 14.3.1 Novartis Company Details

      • 14.3.2 Novartis Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis Generic Oncology Drugs Product and Service

    • 14.4 Merck

      • 14.4.1 Merck Company Details

      • 14.4.2 Merck Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck Generic Oncology Drugs Product and Service

    • 14.5 Celgene

      • 14.5.1 Celgene Company Details

      • 14.5.2 Celgene Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Celgene Generic Oncology Drugs Product and Service

    • 14.6 Teva Pharmaceutical

      • 14.6.1 Teva Pharmaceutical Company Details

      • 14.6.2 Teva Pharmaceutical Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Teva Pharmaceutical Generic Oncology Drugs Product and Service

    • 14.7 Mylan

      • 14.7.1 Mylan Company Details

      • 14.7.2 Mylan Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Mylan Generic Oncology Drugs Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Generic Oncology Drugs Product and Service

    • 14.9 Aurobindo Pharma

      • 14.9.1 Aurobindo Pharma Company Details

      • 14.9.2 Aurobindo Pharma Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Aurobindo Pharma Generic Oncology Drugs Product and Service

    • 14.10 Natco Pharma

      • 14.10.1 Natco Pharma Company Details

      • 14.10.2 Natco Pharma Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Natco Pharma Generic Oncology Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Generic Oncology Drugs

    • Figure Generic Oncology Drugs Picture

    • Table Global Generic Oncology Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Oncology Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Generic Oncology Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Generic Oncology Drugs Consumption by Country (2017-2022)

    • Figure United States Generic Oncology Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Generic Oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Generic Oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Generic Oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Generic Oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Generic Oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Generic Oncology Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Generic Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Generic Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Generic Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Generic Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Generic Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Generic Oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Large Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Small Molecule Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Large Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Generic Oncology Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Generic Oncology Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Generic Oncology Drugs Product and Service

    • Table Hikma Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Hikma Pharmaceuticals Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Pharmaceuticals Generic Oncology Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Generic Oncology Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Generic Oncology Drugs Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Generic Oncology Drugs Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Generic Oncology Drugs Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Generic Oncology Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Generic Oncology Drugs Product and Service

    • Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Pharma Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Generic Oncology Drugs Product and Service

    • Table Natco Pharma (Foundation Year, Company Profile and etc.)

    • Table Natco Pharma Generic Oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natco Pharma Generic Oncology Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US